Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
JPM 2025
Pharma
Astellas shifts investment focus to later-stage programs: exec
As part of a reprioritization, Astellas is shifting its focus more to later-stage opportunities, chief strategy officer Adam Pearson said.
Angus Liu
Feb 12, 2025 1:30pm
Recapping the 2025 J.P. Morgan Healthcare Conference
Jan 24, 2025 9:00am
JPM25: Servier chief on 'staying authentic' as firm grows reach
Jan 23, 2025 1:00pm
JPM25: Incyte plans to turn 'a lot of cards' in 2025, CEO says
Jan 22, 2025 2:38pm
JPM25: Acadia’s new CEO sets sights on company's first $1B year
Jan 17, 2025 1:22pm
JPM25: Bayer gears up for 'must-win battles' amid Xarelto decline
Jan 15, 2025 8:00pm
